The Bionics Institute undertakes innovative research into areas of clinical need to develop medical devices and diagnostic tools which can transform people’s lives. The Institute has a unique set of skills that combine advanced neurological research with leading engineering designs. Our research facilities are housed within St Vincent’s Hospital Melbourne, and we make extensive use of our close proximity to leading clinician-researchers at this and other major hospitals to ensure that all of our research programs are driven by clinical need.

This approach is underpinned by the Institute’s business model that aims to deliver our technologies into clinical applications, which in turn generates revenue that contributes to funding of further research and development. Enhanced by our strong industry and clinical collaborations our capacity for contract research and ensuring research is clinically-relevant and sustainable is increased. 

In 2017, the Bionics Institute recruited Mr Robert Klupacs as CEO. Robert's significant expertise and experience in drug development and commercialisation has helped lead market strategies for all our research, which has already led to the establishment of two start-up companies.

In 2019, we became the first and only Australian Medical Research Institute to receive an internationally recognised accreditation for our Quality Management System (ISO 9001) covering all operations, research and development processes. This accreditation reinforces our commitment to generating real clinical impact from our research and differentiates us from other MRIs and Universities. 

Click here to read about the difference we have made and the list of technologies that have been delivered into clinical outcomes.